For research access and to learn how you can work with Alembic Global Advisors please email Stephen Matthews, stephen.matthews@alembicglobal.com.
Key Points Q1’25 EPS and EBITDA beat but Q2’25 guidance below consensus Alberta project delayed and further cost cuts announced. European review expanded We rate Dow Inc. shares Neutral, with a revised down...
Key Points We’re updating our forecast for RTX post yesterday’s 1Q25 earnings report and we’re lowering our target price by USD17 to USD132. RTX reported a solid 1Q in several respects, but...
Key Points Chemical equities' performance is far worse than what we've seen in recessionary periods over the last 60 years, suggesting limited downside and significant upside Sector balance sheets and cash flows...
Key Points We’re updating our forecast for BA after the company reported its 1Q25 orders and deliveries data last week. BA delivered 130 commercial jets in 1Q vs. our forecast for 118,...
Key Points We believe feedstock costs lagged product prices in Q1'25, we anticipate a weak Q1’25 earnings season Meaningfully above Q1’25 and 2025 consensus for CE and MEOH Meaningfully below consensus in Q1’25...